Last updated: April 19, 2024
Sponsor: Parnassia Groep
Overall Status: Active - Recruiting
Phase
N/A
Condition
Autism Spectrum Disorder (Asd)
Williams Syndrome
Asperger's Disorder
Treatment
N/AClinical Study ID
NCT06375226
2023.17
2023.0871
Ages 18-65 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Inclusion criteria are:
- a primary clinical diagnosis of DSM-5 ASD (APA, 2013)
- age 18 - 65 years
- no intellectual disability (IQ > 80)
Exclusion
Exclusion Criteria:
- acute psychosis
- acute suicidality
- psychotic disorder
- intellectual disability (IQ < 80)
Study Design
Total Participants: 60
Study Start date:
March 01, 2024
Estimated Completion Date:
April 01, 2025
Study Description
Connect with a study center
ParnassiaGroep Antes
Rotterdam, Zuid-Holland 3083 AK
NetherlandsActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.